Staar Surgical Announces Strategic Cooperation Agreement with Vista Oftalmólogos
Staar Surgical Company announced a strategic cooperation agreement with Vista Oftalmólogos, a 49-clinic ophthalmology group spanning Spain, France, Portugal, and Morocco with more than 200 eye doctors and 1,000 employees. The agreement positions the EVO Visian ICL family of lenses as a premium and primary refractive procedure for patients suffering from myopia, which is the need for distance vision correction.
“Providing the highest level of science-backed vision services to ensure satisfied patients is the common endeavor of every Vista clinic and the EVO Visian ICL fulfills that goal fitting seamlessly into our clinics,” Juan Borreguero, Manager of Vista Oftalmólogos, said in a company news release. “Some of our surgeons have used the ICL for years while others are just beginning the journey in providing this life-changing vision correction solution to our patients. With the ICL we have the added plus of a manufacturing company that meets our surgeons’ expectations, which is no small feat in this business. This new strategic cooperation agreement with Staar elevates the importance of the ICL in providing our patients a safe quick vision correction procedure with unmatched levels of patient satisfaction.”
EVO is the latest version of Staar Surgical Company’s implantable collamer lens (ICL) that works in harmony with the patient’s natural eye to correct vision and provide patients visual freedom from spectacles and contact lenses. The central hole of the EVO lens allows for the eye’s natural nourishing aqueous flow and a single surgical procedure. EVO is currently available in over 75 countries outside the U.S. in aspheric, toric, and EVO+ (patients with larger pupil sizes) versions.
“In 10 short years Vista Oftalmólogos has established itself as a leading ophthalmology group in Western Europe and we are delighted they have chosen to make our EVO Visian ICL family of lenses a premium and primary procedure in their clinics,” Caren Mason, President and CEO of Staar Surgical Company, said in a company news release. “Precision manufactured with our exclusive collamer material the EVO lens has a well-recognized safety and effectiveness record for the more than 500,000 EVO lenses that have been implanted. The Staar team looks forward to working closely with Vista Oftalmólogos on certifying surgeons, patient education and marketing to facilitate broader awareness and use of the ICL.”